The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy.
 
Haniel alves Araujo
No Relationships to Disclose
 
Camila Motta Venchiarutti Moniz
No Relationships to Disclose
 
Oddone Freitas Melro Braghiroli
No Relationships to Disclose
 
Milena Perez Mak
Honoraria - MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca
 
Lucas Fernando Uratani
No Relationships to Disclose
 
Ricardo Dahmer Tiecher
No Relationships to Disclose
 
Priscila Muniz Moraes
No Relationships to Disclose
 
Ingrid Barbosa
No Relationships to Disclose
 
Veridiana Pires De Camargo
No Relationships to Disclose
 
Maria Ignez Freitas Melro Braghiroli
No Relationships to Disclose
 
Gilberto Castro
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche; Yuhan
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Paulo Marcelo Hoff
Consulting or Advisory Role - Genzyme (I); United Health Group (I)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Maria Del Pilar Diz
No Relationships to Disclose